Industry pays attention to AZ’s Symbicort Rapihaler

AstraZeneca Korea’s ‘Symbicort Rapihaler’ which strengthened its inhaler portfolio has attracted interests of the industry.

AstraZeneca Korea introduced ‘Symbicort Rapihaler’ through a press conference on the 18^th, and announced to extent the pipeline, such as new drug development and investment for inhalers, in order to provide a wide range of treatment options for inhaler patients.

The co...